SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-018344
Filing Date
2023-11-09
Accepted
2023-11-08 18:19:14
Documents
62
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rsls-20230930x10q.htm   iXBRL 10-Q 1754396
2 EX-31.1 rsls-20230930xex31d1.htm EX-31.1 11733
3 EX-31.2 rsls-20230930xex31d2.htm EX-31.2 11981
4 EX-32.1 rsls-20230930xex32d1.htm EX-32.1 9406
5 EX-32.2 rsls-20230930xex32d2.htm EX-32.2 9219
  Complete submission text file 0001558370-23-018344.txt   6521943

Data Files

Seq Description Document Type Size
6 EX-101.SCH rsls-20230930.xsd EX-101.SCH 40659
7 EX-101.CAL rsls-20230930_cal.xml EX-101.CAL 54222
8 EX-101.DEF rsls-20230930_def.xml EX-101.DEF 213972
9 EX-101.LAB rsls-20230930_lab.xml EX-101.LAB 383646
10 EX-101.PRE rsls-20230930_pre.xml EX-101.PRE 322794
56 EXTRACTED XBRL INSTANCE DOCUMENT rsls-20230930x10q_htm.xml XML 987104
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 949-429-6680
ReShape Lifesciences Inc. (Filer) CIK: 0001427570 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37897 | Film No.: 231389503
SIC: 3841 Surgical & Medical Instruments & Apparatus